Madhav Swaminathan, M.D., FASC, FAHA, clinical director of cardiothoracic anesthesiology, at Duke University Medical Center, discusses use of cardiac ultrasound in cardiac sur
TVT
-
-
A discussion with Rebecca Hahn, M.D., FASE, director of interventional echocardiography and professor of medicine at Columbia University Medical Center / New York-Presbyterian Hospital, New York...
-
June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel Cerebral Protection System (CPS), via de novo classification, enabling U.S.
-
The U.S. Food and Drug Administration (FDA) has granted market clearance for aortic and mitral valve-in-valve procedures using the Edwards Lifesciences Sapien 3 transcatheter heart valve (THV)....
News | Heart Valve Technology | August 03, 2017
Aug. 3, 2017 — 4C Medical Technologies Inc. minimally invasive therapies for structural heart disease said its...
The ChordArt transcatheter mitral valve leaflet chord replacement system on X-ray, showing the anchoring sections of the artificial chord.
News | Heart Valve Technology | August 01, 2017
Aug. 1, 2017 — CoreMedic, a start-up developing the ChordArt trancatheter mitral valve repair system, has received...
News | Leads Implantable Devices | June 20, 2017
June 20, 2017 — BioTrace Medical Inc. announced that the company’s Tempo...
Videos | Cardiovascular Ultrasound | June 15, 2017
Madhav Swaminathan, M.D., FASC, FAHA, clinical director of cardiothoracic anesthesiology, at Duke University Medical...
Mitral valve regurgitation showed on an echocardiogram. Image from Toshiba.
News | Heart Valve Technology | June 15, 2017
June 15, 2017 — 4C Medical Technologies Inc., a developer of minimally invasive therapies for structural heart...
Videos | Heart Valve Technology | June 14, 2017
A discussion with Rebecca Hahn, M.D., FASE, director of interventional echocardiography and professor of medicine at...
Feature | Heart Valve Technology | June 09, 2017
June 5, 2017 – The U.S. Food and Drug Administration (FDA) granted market clearance for the Claret Medical Sentinel ...
Feature | Heart Valve Technology | June 06, 2017 | Dave Fornell
June 6, 2017 — The U.S. Food and Drug Administration (FDA) has granted market clearance for aortic and mitral valve-...
News | Heart Valve Technology | May 24, 2017
May 24, 2017 — Late-breaking data presented at EuroPCR 2017 demonstrating excellent clinical outcomes for...
The Symetis Acurate Neo TAVI valve.
News | Heart Valve Technology | April 11, 2017
April 10, 2017 — Boston Scientific recently announced a $435 million cash deal to acquire Symetis SA, a privately-...
An MRI brain scan showing multiple microbleeds in a transcatheter aortic valve replacement (TAVR) patient from the study.
Feature | Heart Valve Technology | March 23, 2017
March 22, 2017 — A quarter of the patients in a single-center study of 84 patients undergoing transcatheter aortic...
Feature | Heart Valve Technology | March 22, 2017
March 22, 2017 – The U.S. Food and Drug Administration (FDA) and granted market clearance to the Medtronic CoreValve...
A CT study from the RESOLVE Trial showing valve leaflet thrombosis on a TAVR device. The trial examined a range of surgical and transcatheter valves to show thrombosis is found across both types of devices. It also examined if anticoagulation or antiplatelet therapy could reduce thrombosis and allow a greater range of leaflet motion.
Feature | Heart Valve Technology | March 21, 2017
March 21, 2017 — About 12 percent of patients undergoing aortic valve replacement developed non-symptomatic blood...
SURTAVI Trial principal investigator Michael Reardon presents the data as a lake-breaker at ACC 2017.
News | Heart Valve Technology | March 17, 2017 | Dave Fornell
March 17, 2017 - Transcatheter aortic valve replacement (TAVR) was found to be noninferior to surgical aortic valve...
